Statement | 17 October 2012 Tuberculosis MSF response to release of new WHO report on tuberculosis, which reveals growing drug-resistant TB emergency
Statement | 17 September 2012 Intellectual property and trade India MSF statement on India's dismissal of Bayer's request for a stay on compulsory licence
Statement | 14 September 2012 Tuberculosis MSF reaction to US FDA's decision granting priority review to first new TB drug in 50 years 3 min
Statement | 21 August 2012 Intellectual property and trade India Bayer/Natco compulsory licence appeal – hearings postponed
Statement | 25 May 2012 Intellectual property and trade Research and development Vaccines WHA 65: MSF Intervention on Draft Global Vaccine Action Plan 3 min
Statement | 08 May 2012 Intellectual property and trade MSF statement on the EP Committee on Development's draft opinion on ACTA
Statement | 29 November 2011 HIV/AIDS Kenya MSF HIV/AIDS in Kenya: majority of patients with suspect Zidolam-N receive follow-up consultations
Statement | 21 October 2011 Vaccines Intergovernmental Negotiations on Mercury Could Threaten Vaccination Programmes 4 min
